Credit: Getty Images. The recall was initiated due to product stability testing results that did not meet specifications for iron content. Allergan has expanded its December 2017 voluntary recall of ...
THE development of sarcomas in rats after the repeated administration of massive doses of iron-dextran complex has been reported by Richmond 1 and confirmed by Haddow and Horning. 2 The latter were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback